TSRGBlog

Blog

The risks of taking benzodiazepines for more than 2 – 4 weeks

The risks of taking benzodiazepines for more than 2 -4 weeks are finally getting attention in the press and through various new published articles.  TSRG is working with the Alliance for Benzodiazepine Best Practices (Dr. Alexis Ritvo and Bernie Silvernail), the Benzodiazepine Information Coalition (Dr. Christy Huff and Nicole Lamberson), Choices Recovery Training (Ginger Ross), the Colorado Consortium for Prescription Drug Abuse Prevention’s Benzodiazepine

Read More »

Please meet Danielle Edwards, one of TSRG’s 2022 interns!

Danielle Edwards, one of two TSRG interns in 2022, is assisting with the Rural Recovery Network project to investigate the availability of medication-assisted treatment (MAT) in 9 county’s criminal justice facilities in rural southern Colorado. This is part of a MAT expansion project through Colorado SB-21-137.  Danielle is conducting a literature review, transcribing audio, and video files, helping prepare a

Read More »

Substance Abuse Journal article published: Perceived impact of COVID-19 on prevention, treatment, harm reduction, and recovery services for opioid use disorder: National survey of local health departments!

It is with great pleasure that I share our first article utilizing TSRG’s 2020 national survey data has been published in the Substance Abuse Journal! Thank you to everyone who gave us guidance on the survey instrument, collected data, or supported this work.  We are actively working on a second paper and hope to finalize a submission this summer.  https://www.tandfonline.com/doi/full/10.1080/08897077.2022.2060429

Read More »

Surviving Benzodiazepines: A Patient’s and Clinician’s Perspectives!

For more than 4 years, a group of committed doctors, patients, and policy experts have been working to raise awareness about the risk of patients developing BIND (benzodiazepine-induced neurological dysfunction) when benzodiazepines are taken as prescribed for more than 2 – 4 weeks. Carrie Silvernail, RN, and Steve Wright, MD, have comprehensively summarized this risk and the importance of providers

Read More »

Annual Letter 2021

MISSION STATEMENT Our mission is to improve outcomes associated with addiction-prone substances through community outreach and research. About Us The Schreiber Research Group (TSRG) is a research-driven organization that conducts research, performs community outreach, and provides consulting services to positively influence how communities, governments, policymakers, and providers make implementation choices regarding programs and services for addiction-prone substance prevention, treatment, and

Read More »

Colorado Gives Day is here!

This is our final push for Giving Season and our first time participating in Colorado Gives Day.  Please consider supporting TSRG to help us reach our goal of $5000 in private donations for 2021 through the Facebook birthday fundraiser, Giving Tuesday, and Colorado Gives Day.  If we reach 30 donations today, we will be entered into the Colorado Gives Day

Read More »

TSRG’s 1st Giving Season is Here!

MISSION STATEMENT Our mission is to find solutions to help solve the substance use crisis through research and community outreach. To do this, TSRG must understand the literature, the evidence-base and what is happening on the ground at intercept points. Read more MESSAGE FROM CEO TSRG continues to be in a growth phase. As we head into giving season, we

Read More »

Art Winners Announced!

It’s been an exciting week at TSRG! We wrapped up our first student art contest with the Challenge School and have selected 16 winners.  We received a total of 104 entries from grades K-11. A special thank you to the Challenge School team, Mr. De la Cruz, art teacher extraordinaire, Principal David Strohfus, and Office Manager Rhonda Clark for helping

Read More »

Exciting week ahead!

This week we will be receiving all the student submissions for our art contest. Students were asked to create an original piece of art that reflects what health, hope, and wellness look like in the time of COVID. We will be turning the winning entries into note cards for our donors. We look forward to sharing the winners ahead of

Read More »

Community Partner Testimonial

Between now and Giving Season, TSRG will highlight testimonials from community partners and student interns. This week, Kristin Carpenter, Program Director at the Otero County Health Department, shares the value of collaborative partnerships that bring research and community outreach to rural communities in their effort to find solutions to the opioid crisis.   

Read More »

The risks of taking benzodiazepines for more than 2 – 4 weeks

The risks of taking benzodiazepines for more than 2 -4 weeks are finally getting attention in the press and through various new published articles.  TSRG is working with the Alliance for Benzodiazepine Best Practices (Dr. Alexis Ritvo and Bernie Silvernail), the Benzodiazepine Information Coalition (Dr. Christy Huff and Nicole Lamberson), Choices Recovery Training (Ginger Ross), the Colorado Consortium for Prescription Drug Abuse Prevention’s Benzodiazepine

Read More »

Please meet Danielle Edwards, one of TSRG’s 2022 interns!

Danielle Edwards, one of two TSRG interns in 2022, is assisting with the Rural Recovery Network project to investigate the availability of medication-assisted treatment (MAT) in 9 county’s criminal justice facilities in rural southern Colorado. This is part of a MAT expansion project through Colorado SB-21-137.  Danielle is conducting a literature review, transcribing audio, and video files, helping prepare a

Read More »

Substance Abuse Journal article published: Perceived impact of COVID-19 on prevention, treatment, harm reduction, and recovery services for opioid use disorder: National survey of local health departments!

It is with great pleasure that I share our first article utilizing TSRG’s 2020 national survey data has been published in the Substance Abuse Journal! Thank you to everyone who gave us guidance on the survey instrument, collected data, or supported this work.  We are actively working on a second paper and hope to finalize a submission this summer.  https://www.tandfonline.com/doi/full/10.1080/08897077.2022.2060429

Read More »

Surviving Benzodiazepines: A Patient’s and Clinician’s Perspectives!

For more than 4 years, a group of committed doctors, patients, and policy experts have been working to raise awareness about the risk of patients developing BIND (benzodiazepine-induced neurological dysfunction) when benzodiazepines are taken as prescribed for more than 2 – 4 weeks. Carrie Silvernail, RN, and Steve Wright, MD, have comprehensively summarized this risk and the importance of providers

Read More »

Annual Letter 2021

MISSION STATEMENT Our mission is to improve outcomes associated with addiction-prone substances through community outreach and research. About Us The Schreiber Research Group (TSRG) is a research-driven organization that conducts research, performs community outreach, and provides consulting services to positively influence how communities, governments, policymakers, and providers make implementation choices regarding programs and services for addiction-prone substance prevention, treatment, and

Read More »

Colorado Gives Day is here!

This is our final push for Giving Season and our first time participating in Colorado Gives Day.  Please consider supporting TSRG to help us reach our goal of $5000 in private donations for 2021 through the Facebook birthday fundraiser, Giving Tuesday, and Colorado Gives Day.  If we reach 30 donations today, we will be entered into the Colorado Gives Day

Read More »